http://www.aktiencheck.de aktiencheck.de aktiencheck.de Fri, 17 Apr 2026 16:48:36 +0200 2 http://www.aktiencheck.de/forum/Applied_DNA_Mpox_Virus_Assay-A418YA-t585530 http://www.aktiencheck.de/forum/Applied_DNA_Mpox_Virus_Assay-A418YA-t585530 Report 9.10.2024 Earnings Call Highlights, Quelle: https://finance.yahoo.com/news/applied-dna-sciences-inc-apdn-215505045. [<a href="http://www.aktiencheck.de/forum/Applied_DNA_Mpox_Virus_Assay-A418YA-t585530">mehr</a>] http://www.aktiencheck.de/forum/Applied_DNA_Sciences-A418YA-t579780 http://www.aktiencheck.de/forum/Applied_DNA_Sciences-A418YA-t579780 hi, STONY BROOK, N.Y., September 06, 2022--(BUSINESS WIRE)--Applied DNA Sciences, Inc. (NASDAQ: APDN) ("Applied DNA" or the "Company"), a leader in PCR-based DNA technologies, announced today that its wholly-owned clinical laboratory subsidiary, Applied DNA Clinical Labs, LLC ("ADCL"), has launched monkeypox testing as a clinical reference laboratory testing service available to hospital systems and clinical labs located in New York State and in states that recognize New York's CLEP/CLIA certification for testing. The launch follows ADCL’s receipt of full approval from the New York State Department of Health (NYSDOH) for its Linea Monkeypox Virus 1.0 Assay as a Laboratory Developed Test (LDT) for the detection of the Clade II variant of the monkeypox virus that is currently prevalent in the U.S. As of September 2, according to the CDC, there are approximately 20,000 cases of monkeypox in the United States with New York State reporting the second-highest number of infections nationally [<a href="http://www.aktiencheck.de/forum/Applied_DNA_Sciences-A418YA-t579780">mehr</a>]